262 related articles for article (PubMed ID: 33574910)
1. Umbilical cord-derived mesenchymal stem cells exert anti-fibrotic action on hypertrophic scar-derived fibroblasts in co-culture by inhibiting the activation of the TGF β1/Smad3 pathway.
Meng X; Gao X; Chen X; Yu J
Exp Ther Med; 2021 Mar; 21(3):210. PubMed ID: 33574910
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Pathological Phenotype of Hypertrophic Scar Fibroblasts Via Coculture with Adipose-Derived Stem Cells.
Deng J; Shi Y; Gao Z; Zhang W; Wu X; Cao W; Liu W
Tissue Eng Part A; 2018 Mar; 24(5-6):382-393. PubMed ID: 28562226
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of lysyl oxidase like 1 inhibits the proliferation and pro-fibrotic effects of transforming growth factor-β1-induced hypertrophic scar fibroblasts.
Ying M; Chen Y; Yuan B
Can J Physiol Pharmacol; 2021 Dec; 99(12):1272-1279. PubMed ID: 34283938
[TBL] [Abstract][Full Text] [Related]
4. Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis.
Li Y; Zhang J; Shi J; Liu K; Wang X; Jia Y; He T; Shen K; Wang Y; Liu J; Zhang W; Wang H; Zheng Z; Hu D
Stem Cell Res Ther; 2021 Mar; 12(1):221. PubMed ID: 33789737
[TBL] [Abstract][Full Text] [Related]
5. Thrombospondin-4 critically controls transforming growth factor β1 induced hypertrophic scar formation.
Qian W; Li N; Cao Q; Fan J
J Cell Physiol; 2018 Jan; 234(1):731-739. PubMed ID: 30132849
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
7. ALA-PDT promotes the death and contractile capacity of hypertrophic scar fibroblasts through inhibiting the TGF-β1/Smad2/3/4 signaling pathway.
Qu Z; Chen Y; Du K; Qiao J; Chen L; Chen J; Wei L
Photodiagnosis Photodyn Ther; 2024 Feb; 45():103915. PubMed ID: 38128289
[TBL] [Abstract][Full Text] [Related]
8. [Effects of silencing Smad ubiquitination regulatory factor 2 on the function of human hypertrophic scar-derived fibroblasts].
Zhang Z; Kuang F; Liu CL; Chen B; Tang WB; Li XJ
Zhonghua Shao Shang Za Zhi; 2017 Mar; 33(3):145-151. PubMed ID: 28316163
[No Abstract] [Full Text] [Related]
9. [Mechanism of transcriptional regulation of Meox1 by transforming growth factor β (1) and its effect on cell migration of adult human dermal fibroblasts].
Wei ZY; Li HS; Zhou JY; Han C; Dong H; Wu YZ; He WF; Tian Y; Luo GX
Zhonghua Shao Shang Za Zhi; 2020 Mar; 36(3):224-233. PubMed ID: 32241049
[No Abstract] [Full Text] [Related]
10. Ellagic acid inhibits the formation of hypertrophic scars by suppressing TGF-β/Smad signaling pathway activity.
Zhao ZJ; Wu DJ; Lv DL; Zhang BD; Chen L; Sun YQ
Chem Biol Drug Des; 2023 Oct; 102(4):773-781. PubMed ID: 37386691
[TBL] [Abstract][Full Text] [Related]
11. Shikonin reduces TGF-β1-induced collagen production and contraction in hypertrophic scar-derived human skin fibroblasts.
Fan C; Dong Y; Xie Y; Su Y; Zhang X; Leavesley D; Upton Z
Int J Mol Med; 2015 Oct; 36(4):985-91. PubMed ID: 26239419
[TBL] [Abstract][Full Text] [Related]
12. Adipose-derived mesenchymal stem cells inhibit cell proliferation and migration and suppress extracellular matrix synthesis in hypertrophic-scar and keloid fibroblasts.
Xie F; Teng L; Xu J; Lu J; Zhang C; Yang L; Ma X; Zhao M
Exp Ther Med; 2021 Feb; 21(2):139. PubMed ID: 33456506
[TBL] [Abstract][Full Text] [Related]
13. Corilagin alleviates hypertrophic scars via inhibiting the transforming growth factor (TGF)-β/Smad signal pathway.
Li Y; Yu Z; Zhao D; Han D
Life Sci; 2021 Jul; 277():119483. PubMed ID: 33862115
[TBL] [Abstract][Full Text] [Related]
14. Centella triterpenes cream as a potential drug for the treatment of hypertrophic scar through inhibiting the phosphorylation of STAT3: A network pharmacology analysis and in vitro experiments.
Tan M; Wu D; Zhou Y; Duan B
J Cosmet Dermatol; 2023 Dec; 22(12):3511-3519. PubMed ID: 37563868
[TBL] [Abstract][Full Text] [Related]
15. Anti-fibrotic actions of interleukin-10 against hypertrophic scarring by activation of PI3K/AKT and STAT3 signaling pathways in scar-forming fibroblasts.
Shi J; Li J; Guan H; Cai W; Bai X; Fang X; Hu X; Wang Y; Wang H; Zheng Z; Su L; Hu D; Zhu X
PLoS One; 2014; 9(5):e98228. PubMed ID: 24878845
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte Growth Factor Secreted from Human Adipose-Derived Stem Cells Inhibits Fibrosis in Hypertrophic Scar Fibroblasts.
Ma J; Yan X; Lin Y; Tan Q
Curr Mol Med; 2020; 20(7):558-571. PubMed ID: 31903876
[TBL] [Abstract][Full Text] [Related]
17. Curcumin alleviates hypertrophic scarring by inhibiting fibroblast activation and regulating tissue inflammation.
Fei H; Qian Y; Pan T; Wei Y; Hu Y
J Cosmet Dermatol; 2024 Jan; 23(1):227-235. PubMed ID: 37400988
[TBL] [Abstract][Full Text] [Related]
18. [Effects and mechanism of age on the stiffness and the fibrotic phenotype of fibroblasts of human hypertrophic scar].
Zhu DZ; Yao B; Cui XL; Huang S; Fu X
Zhonghua Shao Shang Za Zhi; 2021 Oct; 37(10):937-945. PubMed ID: 34689463
[No Abstract] [Full Text] [Related]
19. miR-145-5p attenuates hypertrophic scar via reducing Smad2/Smad3 expression.
Shen W; Wang Y; Wang D; Zhou H; Zhang H; Li L
Biochem Biophys Res Commun; 2020 Jan; 521(4):1042-1048. PubMed ID: 31732152
[TBL] [Abstract][Full Text] [Related]
20. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
Zhou C; Liu F; Gallo PH; Baratz ME; Kathju S; Satish L
BMC Musculoskelet Disord; 2016 Nov; 17(1):469. PubMed ID: 27835939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]